PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen. - Wikidata - wikimedia - TriplyDB

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

http://www.wikidata.org/entity/Q51766972

about

Mapping biological behaviors by application of longer-lived positron emitting radionuclides Prostate cancer relevant antigens and enzymes for targeted drug delivery Molecular imaging: current status and emerging strategies.'Image and treat': an individualized approach to urological tumors GCPII imaging and cancer.Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo New agents and techniques for imaging prostate cancer.Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging Functional imaging for prostate cancer: therapeutic implications.Molecular imaging of prostate cancer: PET radiotracers.Prostate specific membrane antigen- a target for imaging and therapy with radionuclides.Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry.Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancer A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.Translational Molecular Imaging of Prostate Cancer.Serially heterotransplanted human prostate tumours as an experimental model Putative molecular signatures for the imaging of prostate cancer.Modalities for imaging of prostate cancer.The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer Prostate-specific membrane antigen-based imaging.Functional imaging for radiotherapy treatment planning: current status and future directions-a review.The clinical and therapeutic uses of MDM2 and PSMA and their potential interaction in aggressive cancers.⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer.Current use of PSMA-PET in prostate cancer management.Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody.Radiofluorination of PSMA-HBED via Al(18)F(2+) Chelation and Biological Evaluations In Vitro.Preparation and evaluation of carborane-derived inhibitors of prostate specific membrane antigen (PSMA).Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer.

P2860

Q26824070-DF9CB2D2-6393-46EC-BEC7-EF41E5CF153F Q27013843-3A8F4110-E8D2-4F65-B574-2D6F1D0C19E0 Q30474579-170A7BB8-4C40-400B-A173-7555737B46A6 Q33792596-9EEC810F-B827-4007-B64B-9E205238AA4B Q33827632-7764D50F-C82A-44BE-9EE6-B90881F7222A Q34038524-A180A18A-48BA-4043-857F-55AFD0408765 Q34152258-86CD29D5-723A-416E-95AE-7F2A8EA12188 Q34196254-CC118436-54BD-429E-A3B9-7003333EAEC6 Q34509927-7FA017FE-603E-4A24-95AA-CBD2173BF674 Q35911784-ACAA422F-51A8-40CA-A1FA-EA1FD74B6A11 Q36125199-2616E5BA-18E3-424F-BBFB-8FA19583CC08 Q36128629-B6822AE9-BE65-42A1-BC5F-6E5CAEB8ACA1 Q36129937-5AB382AC-E582-4217-BB71-3FA7002236A7 Q36135685-AD436AFE-D27C-4FF6-AF59-BFA012D570A1 Q36160805-407DCBF1-FD58-4D80-AD7E-38E8399AAA56 Q36339722-09D44CD1-7806-419C-9CBA-07EEEE4A6E74 Q36363280-D5017CF2-C0E4-485A-98A8-2D96A686165B Q36557471-CC2E6EA0-76DE-45A7-8E3B-728D6F7453F5 Q37091554-8CEE8DC1-8EF9-431F-BFBE-65A9EEB1B3F9 Q37108209-7F615CC6-6732-497F-85C9-21D81DDE16C0 Q37172093-065C22F5-97D7-41BD-99B7-B760345C984A Q37244969-83F8820F-BA4E-4656-A8DD-1089DDF95306 Q37310963-B30CBC76-BFE3-4EBC-A0A2-F284F9E1FDF0 Q37656266-6A7807E6-D396-4174-84D9-EDD9A7ED3AED Q37719273-058DC987-3772-453A-8B07-F5F3537F603B Q37869905-65A1182B-B66D-45BE-B16F-1895CBE2B7E1 Q37972920-1C4AD0AD-E5CD-4410-B599-0A059A8CA2BC Q38015617-47B00A04-3763-418A-B8EB-632435EE664B Q38397651-B21F7091-7105-41B3-9D81-2A2A8512E905 Q38637803-6B4F0E9B-233A-4FEC-AEEA-C1638198794C Q38705627-F20AF7BD-C3E9-4D84-96CB-2E3D2A761CBE Q38744524-64B999A9-11F8-4CD9-BF91-A5C72875B2A4 Q38962393-2342B3D8-B74C-4E3E-B80B-449EB22AA0B8 Q39017235-B93457B5-424F-4246-B663-1DF114158201 Q39018543-AD27BEBE-77DE-41D8-B509-269BE2963A75 Q39028837-03C77AA6-648E-4B97-AA5C-C03893ED8D5F Q39070519-9704416F-8583-4B99-9B2F-040A39A2E7B1 Q39417962-1428C111-58F2-48B0-BD0B-08ECAFD853A3 Q39449818-266B4318-11DA-474C-B7EB-C088AC8628DF Q41600550-6BE80BE6-08A0-4F69-A377-631512870996

P2860

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

http://www.wikidata.org/entity/Q51766972

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

PET imaging of prostate cancer ...... ate-specific membrane antigen.

@en

PET imaging of prostate cancer ...... ate-specific membrane antigen.

@nl

type

label

PET imaging of prostate cancer ...... ate-specific membrane antigen.

@en

PET imaging of prostate cancer ...... ate-specific membrane antigen.

@nl

prefLabel

PET imaging of prostate cancer ...... ate-specific membrane antigen.

@en

PET imaging of prostate cancer ...... ate-specific membrane antigen.

@nl

P1433

Q51766972-2F631241-4629-422F-A965-B8B18535202A

P1476

Q51766972-4C6CFE49-4870-444F-999E-C396A2449662

P2093

Q51766972-4336D990-6519-4DDF-AA4D-CC8D993EF2A1

Q51766972-6C31B014-1AF7-4834-A770-81A863F650D7

Q51766972-7F305847-CEB0-4538-A490-6D8C62282E8E

Q51766972-9426CCAF-06DC-4A61-819B-C54ECE6EC54D

Q51766972-B7C84916-FBF6-4C90-AAA5-7BDFB8F6681E

Q51766972-D350CCAB-F40D-42E6-B0C5-2186824D720B

Q51766972-D5286F2C-BB13-4BAE-B651-FC2DC17F2D31

Q51766972-E6CA5304-3C30-45EA-B3C6-AC0E7B0C47D1

P304

Q51766972-112F154E-9846-47B9-A0DA-2C02792E1BB6

P31

Q51766972-C317E192-1BAC-4602-B312-E8B15177E9E5

P356

Q51766972-98C5A5EA-40ED-4DB5-A4E9-7E16B31639AA

P407

Q51766972-9F729FE8-E673-40C2-BEA9-501A90E8EEEC

P433

Q51766972-497D3C5D-43C1-429A-8A2C-EA8F459D6197

P478

Q51766972-C4C89915-7891-4FBC-84F3-91E8D187C25E

P50

Q51766972-484C983B-130F-40DF-8199-6B185CA54EB8

Q51766972-61D83BA0-8905-417B-B790-67ECB30552CD

P577

Q51766972-BB254834-D040-4F1A-AB77-62A85274C9C6

P698

Q51766972-699B1A9C-A8D9-4C14-B583-0F3C139D62CD

P921

Q51766972-5ECB2C1A-C46F-4E0D-95D6-F8A50DFFF345

Q51766972-625ED4DE-AC1C-49C2-BBA4-0AB72870B44C

P356

JNUMED.108.058487

P1433

The Journal of Nuclear Medicine

P1476

PET imaging of prostate cancer ...... tate-specific membrane antigen

@en

P2093

Bernd J Pichler

http://www.w3.org/2001/XMLSchema#string

Gerald Reischl

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Machulla

http://www.w3.org/2001/XMLSchema#string

John Shively

http://www.w3.org/2001/XMLSchema#string

Martin S Judenhofer

http://www.w3.org/2001/XMLSchema#string

Patrick Bühler

http://www.w3.org/2001/XMLSchema#string

Stefan Wiehr

http://www.w3.org/2001/XMLSchema#string

Ursula Elsässer-Beile

http://www.w3.org/2001/XMLSchema#string

P304

606-611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.108.058487

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19289418

http://www.w3.org/2001/XMLSchema#string

P921